and population-level health consequences of discontinuing antiretroviral therapy in settings with

Short-term discontinuation of HAART regimens more common in vulnerable patient populations

Robison, Lindsay S.
Westfall, Andrew O.
Mugavero, Michael J.
Kempf, Mirjam
Cole, Stephen R.
Allison, Jeroan J.
Willig, James H.
Raper, James L
Wilcox, C. Mel
Saag, Michael S.

November 2008

The durability of HAART regimens is often limited by antiretroviral toxicity and nonadherence, which...

Discontinuation of Initial Antiretroviral Therapy in Clinical Practice: Moving Toward Individualized Therapy.

Di Biagio, Antonio
Cozzi Lepri, Alessandro
Prinapori, Roberta
Angarano, Gioacchino
Gori, Andrea
Quirino, Tiziana
De Luca, Andrea
Mussini, Cristina
Rizzardini, Giuliano
Castagna, Antonella
Antinori, Andrea
dʼArminio Monforte, Antonella
COSTANTINI, ANDREA

January 2016

Background: Study aim was to estimate the rate and identify predictors of discontinuation of first c...

Insights into reasons for discontinuation according to year of starting first regimen of highly active antiretroviral therapy in a cohort of antiretroviral-naïve patients

Cicconi, P
Cozzi Lepri, A
Castagna, A
Trecarichi, EM
Antinori, A
Gatti, F
Cassola, G
Sighinolfi, L
Castelli, P
d'Arminio Monforte, A
PERNO, CARLO FEDERICO

February 2010

The aim of the study was to determine whether the incidence of first-line treatment discontinuations...

Authors

April D. Kimmel
Stephen C. Resch
Xavier Anglaret
April D. Kimmel
Stephen C. Resch
Xavier Anglaret
Norman Daniels
Sue J. Goldie
Christine Daniel
Y. Wong
Kenneth A. Freedberg
Milton C. Weinstein
April D Kimmel
Stephen C Resch
Xavier Anglaret
Norman Daniels
Sue J Goldie
Christine Danel
Angela Y Wong
Kenneth A Freedberg
Milton C Weinstein

October 2016

Patient- and population-level health consequences of discontinuing antiretroviral therapy in setting...

Incidence of discontinuation of highly active antiretroviral combination therapy (HAART) and its determinants

van Roon, E N
Verzijl, J M
Juttmann, J R
Lenderink, A W
Blans, M J
Egberts, A C

March 1999

OBJECTIVE: To determine the incidence and determinants for discontinuation of initial highly active ...

Patient- and population-level health consequences of discontinuing antiretroviral therapy in settings with inadequate HIV treatment availability.

Kimmel, April
Resch, Stephen
Anglaret, Xavier
Daniels, Norman
Goldie, Sue
Danel, Christine
Wong, Angela
Freedberg, Kenneth
Weinstein, Milton

September 2012

International audienceABSTRACT: BACKGROUND: In resource-limited settings, HIV budgets are flattening...

Discontinuation of initial antiretroviral therapy in clinical practice: Moving toward individualized therapy

Di Biagio, Antonio
Cozzi Lepri, Alessandro
Prinapori, Roberta
Angarano, Gioacchino
Gori, Andrea
Quirino, Tiziana
De Luca, Andrea
Costantini, Andrea
Mussini, Cristina
Rizzardini, Giuliano
Castagna, Antonella
Antinori, Andrea
d'Arminio Monforte, Antonella
for the ICONA Foundation Study Group: [. . .
. . . ]
VIALE, PIERLUIGI
VANINO, ELISA
VERUCCHI, GABRIELLA

January 2016

ackground: Study aim was to estimate the rate and identify predictors of discontinuation of first co...

Discontinuation of initial antiretroviral therapy in clinical practice : Moving toward individualized therapy

A. Di Biagio
A. Cozzi Lepri
R. Prinapori
G. Angarano
A. Gori
T. Quirino
A. De Luca
A. Costantini
C. Mussini
G. Rizzardini
A. Castagna
A. Antinori
A.D. Monforte
M. Moroni
M. Andreoni
G. Angarano
A. Antinori
A. D&apos
F. Castelli
R. Cauda
G. Di Perri
M. Galli
R. Iardino
G. Ippolito
A. Lazzarin
C.F. Perno
F. Von Schloesser
P. Viale
A. D&apos
A. Antinori
A. Castagna
F. Ceccherini Silberstein
A. Cozzi Lepri
E. Girardi
S. Lo Caputo
C. Mussini
M. Puoti
M. Andreoni
A. Ammassari
A. Antinori
C. Balotta
A. Bandera
P. Bonfanti
S. Bonora
M. Borderi
A. Calcagno
L. Calza
M.R. Capobianchi
A. Castagna
F. Ceccherini Silberstein
A. Cingolani
P. Cinque
A. Cozzi Lepri
A. D&apos
A. De Luca
A. Di Biagio
E. Girardi
N. Gianotti
A. Gori
G. Guaraldi
G. Lapadula
M. Lichtner
S. Lo Caputo
G. Madeddu
F. Maggiolo
G. Marchetti
S. Marcotullio
L. Monno
C. Mussini
M. Puoti
E. Quiros Roldan
R. Rossotti
S. Rusconi
M. Santoro
A. Saracino
M. Zaccarelli
A. Cozzi Lepri
I. Fanti
L. Galli
P. Lorenzini
A. Rodano
M. Shanyinde
A. Tavelli
A. Giacometti
A. Costantini
S. Mazzoccato
G. Angarano
L. Monno
C. Santoro
F. Maggiolo
C. Suardi
P. Viale
E. Vanino
G. Verucchi
F. Castelli
E. Quiros Roldan
C. Minardi
T. Quirino
C. Abeli
P.E. Manconi
P. Piano
J. Vecchiet
K. Falasca
L. Sighinolfi
D. Segala
F. Mazzotta
S. Lo Caputo
G. Cassola
C. Viscoli
A. Alessandrini
R. Piscopo
G. Mazzarello
C. Mastroianni
V. Belvisi
P. Bonfanti
I. Caramma
A. Chiodera
A.P. Castelli
M. Galli
A. Lazzarin
G. Rizzardini
M. Puoti
A. D&apos
A.L. Ridolfo
R. Piolini
A. Castagna
S. Salpietro
L. Carenzi
M.C. Moioli
C. Tincati
G. Marchetti
C. Mussini
C. Puzzolante
A. Gori
G. Lapadula
N. Abrescia
A. Chirianni
G. Borgia
M.G. Guida
M. Gargiulo
I. Gentile
R. Orlando
F. Baldelli
D. Francisci
G. Parruti
T. Ursini
G. Magnani
M.A. Ursitti
R. Cauda
M. Andreoni
A. Antinori
V. Vullo
A. Cingolani
A. D&apos
L. Gallo
E. Nicastri
R. Acinapura
M. Capozzi
R. Libertone
G. Tebano
M. Zaccarelli
F. Viviani
L. Sasset
M.S. Mura
G. Madeddu
A. De Luca
B. Rossetti
P. Caramello
G. Di Perri
G.C. Orofino
S. Bonora
M. Sciandra
M. Bassetti
A. Londero
G. Pellizzer
V. Manfrin

January 2016

Background: Study aim was to estimate the rate and identify predictors of discontinuation of first c...

Regimens used following discontinuation of randomized treatment in the ACTG 5257 clinical trial and associated antiretroviral drug costs.

Anita J. Brogan (531402)
Ashley E. Davis (5703554)
Bridgett Goodwin (5703557)

August 2018

Regimens used following discontinuation of randomized treatment in the ACTG 5257 clinical trial and ...

Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naïve patients. I.CO.N.A. Study Group. Italian Cohort of Antiretroviral-Naïve Patients

d'Arminio Monforte, A
Lepri, A C
Rezza, G
Pezzotti, P
Antinori, A
Phillips, A N
Angarano, G
Colangeli, V
De Luca, A
Ippolito, G
Caggese, L
Soscia, F
Filice, G
Gritti, F
Narciso, P
Tirelli, U
Moroni, M

January 2000

To evaluate the frequency of discontinuation of the first highly active antiretroviral regimen (HAAR...

Short-term discontinuation of HAART regimens more common in vulnerable patient populations

Robison, Lindsay S.
Westfall, Andrew O.
Mugavero, Michael J.
Kempf, Mirjam
Cole, Stephen R.
Allison, Jeroan J.
Willig, James H.
Raper, James L
Wilcox, C. Mel
Saag, Michael S.

November 2008

The durability of HAART regimens is often limited by antiretroviral toxicity and nonadherence, which...

Discontinuation of Initial Antiretroviral Therapy in Clinical Practice: Moving Toward Individualized Therapy.

Di Biagio, Antonio
Cozzi Lepri, Alessandro
Prinapori, Roberta
Angarano, Gioacchino
Gori, Andrea
Quirino, Tiziana
De Luca, Andrea
Mussini, Cristina
Rizzardini, Giuliano
Castagna, Antonella
Antinori, Andrea
dʼArminio Monforte, Antonella
COSTANTINI, ANDREA

January 2016

Background: Study aim was to estimate the rate and identify predictors of discontinuation of first c...

Insights into reasons for discontinuation according to year of starting first regimen of highly active antiretroviral therapy in a cohort of antiretroviral-naïve patients

Cicconi, P
Cozzi Lepri, A
Castagna, A
Trecarichi, EM
Antinori, A
Gatti, F
Cassola, G
Sighinolfi, L
Castelli, P
d'Arminio Monforte, A
PERNO, CARLO FEDERICO

February 2010

The aim of the study was to determine whether the incidence of first-line treatment discontinuations...

Authors

April D. Kimmel
Stephen C. Resch
Xavier Anglaret
April D. Kimmel
Stephen C. Resch
Xavier Anglaret
Norman Daniels
Sue J. Goldie
Christine Daniel
Y. Wong
Kenneth A. Freedberg
Milton C. Weinstein
April D Kimmel
Stephen C Resch
Xavier Anglaret
Norman Daniels
Sue J Goldie
Christine Danel
Angela Y Wong
Kenneth A Freedberg
Milton C Weinstein

October 2016

Patient- and population-level health consequences of discontinuing antiretroviral therapy in setting...

Incidence of discontinuation of highly active antiretroviral combination therapy (HAART) and its determinants

van Roon, E N
Verzijl, J M
Juttmann, J R
Lenderink, A W
Blans, M J
Egberts, A C

March 1999

OBJECTIVE: To determine the incidence and determinants for discontinuation of initial highly active ...

Patient- and population-level health consequences of discontinuing antiretroviral therapy in settings with inadequate HIV treatment availability.

Kimmel, April
Resch, Stephen
Anglaret, Xavier
Daniels, Norman
Goldie, Sue
Danel, Christine
Wong, Angela
Freedberg, Kenneth
Weinstein, Milton

September 2012

International audienceABSTRACT: BACKGROUND: In resource-limited settings, HIV budgets are flattening...

Discontinuation of initial antiretroviral therapy in clinical practice: Moving toward individualized therapy

Di Biagio, Antonio
Cozzi Lepri, Alessandro
Prinapori, Roberta
Angarano, Gioacchino
Gori, Andrea
Quirino, Tiziana
De Luca, Andrea
Costantini, Andrea
Mussini, Cristina
Rizzardini, Giuliano
Castagna, Antonella
Antinori, Andrea
d'Arminio Monforte, Antonella
for the ICONA Foundation Study Group: [. . .
. . . ]
VIALE, PIERLUIGI
VANINO, ELISA
VERUCCHI, GABRIELLA

January 2016

ackground: Study aim was to estimate the rate and identify predictors of discontinuation of first co...

Discontinuation of initial antiretroviral therapy in clinical practice : Moving toward individualized therapy

A. Di Biagio
A. Cozzi Lepri
R. Prinapori
G. Angarano
A. Gori
T. Quirino
A. De Luca
A. Costantini
C. Mussini
G. Rizzardini
A. Castagna
A. Antinori
A.D. Monforte
M. Moroni
M. Andreoni
G. Angarano
A. Antinori
A. D&apos
F. Castelli
R. Cauda
G. Di Perri
M. Galli
R. Iardino
G. Ippolito
A. Lazzarin
C.F. Perno
F. Von Schloesser
P. Viale
A. D&apos
A. Antinori
A. Castagna
F. Ceccherini Silberstein
A. Cozzi Lepri
E. Girardi
S. Lo Caputo
C. Mussini
M. Puoti
M. Andreoni
A. Ammassari
A. Antinori
C. Balotta
A. Bandera
P. Bonfanti
S. Bonora
M. Borderi
A. Calcagno
L. Calza
M.R. Capobianchi
A. Castagna
F. Ceccherini Silberstein
A. Cingolani
P. Cinque
A. Cozzi Lepri
A. D&apos
A. De Luca
A. Di Biagio
E. Girardi
N. Gianotti
A. Gori
G. Guaraldi
G. Lapadula
M. Lichtner
S. Lo Caputo
G. Madeddu
F. Maggiolo
G. Marchetti
S. Marcotullio
L. Monno
C. Mussini
M. Puoti
E. Quiros Roldan
R. Rossotti
S. Rusconi
M. Santoro
A. Saracino
M. Zaccarelli
A. Cozzi Lepri
I. Fanti
L. Galli
P. Lorenzini
A. Rodano
M. Shanyinde
A. Tavelli
A. Giacometti
A. Costantini
S. Mazzoccato
G. Angarano
L. Monno
C. Santoro
F. Maggiolo
C. Suardi
P. Viale
E. Vanino
G. Verucchi
F. Castelli
E. Quiros Roldan
C. Minardi
T. Quirino
C. Abeli
P.E. Manconi
P. Piano
J. Vecchiet
K. Falasca
L. Sighinolfi
D. Segala
F. Mazzotta
S. Lo Caputo
G. Cassola
C. Viscoli
A. Alessandrini
R. Piscopo
G. Mazzarello
C. Mastroianni
V. Belvisi
P. Bonfanti
I. Caramma
A. Chiodera
A.P. Castelli
M. Galli
A. Lazzarin
G. Rizzardini
M. Puoti
A. D&apos
A.L. Ridolfo
R. Piolini
A. Castagna
S. Salpietro
L. Carenzi
M.C. Moioli
C. Tincati
G. Marchetti
C. Mussini
C. Puzzolante
A. Gori
G. Lapadula
N. Abrescia
A. Chirianni
G. Borgia
M.G. Guida
M. Gargiulo
I. Gentile
R. Orlando
F. Baldelli
D. Francisci
G. Parruti
T. Ursini
G. Magnani
M.A. Ursitti
R. Cauda
M. Andreoni
A. Antinori
V. Vullo
A. Cingolani
A. D&apos
L. Gallo
E. Nicastri
R. Acinapura
M. Capozzi
R. Libertone
G. Tebano
M. Zaccarelli
F. Viviani
L. Sasset
M.S. Mura
G. Madeddu
A. De Luca
B. Rossetti
P. Caramello
G. Di Perri
G.C. Orofino
S. Bonora
M. Sciandra
M. Bassetti
A. Londero
G. Pellizzer
V. Manfrin

January 2016

Background: Study aim was to estimate the rate and identify predictors of discontinuation of first c...

Regimens used following discontinuation of randomized treatment in the ACTG 5257 clinical trial and associated antiretroviral drug costs.

Anita J. Brogan (531402)
Ashley E. Davis (5703554)
Bridgett Goodwin (5703557)

August 2018

Regimens used following discontinuation of randomized treatment in the ACTG 5257 clinical trial and ...

Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naïve patients. I.CO.N.A. Study Group. Italian Cohort of Antiretroviral-Naïve Patients

d'Arminio Monforte, A
Lepri, A C
Rezza, G
Pezzotti, P
Antinori, A
Phillips, A N
Angarano, G
Colangeli, V
De Luca, A
Ippolito, G
Caggese, L
Soscia, F
Filice, G
Gritti, F
Narciso, P
Tirelli, U
Moroni, M

January 2000

To evaluate the frequency of discontinuation of the first highly active antiretroviral regimen (HAAR...

Short-term discontinuation of HAART regimens more common in vulnerable patient populations

Robison, Lindsay S.
Westfall, Andrew O.
Mugavero, Michael J.
Kempf, Mirjam
Cole, Stephen R.
Allison, Jeroan J.
Willig, James H.
Raper, James L
Wilcox, C. Mel
Saag, Michael S.

November 2008

The durability of HAART regimens is often limited by antiretroviral toxicity and nonadherence, which...

Discontinuation of Initial Antiretroviral Therapy in Clinical Practice: Moving Toward Individualized Therapy.

Di Biagio, Antonio
Cozzi Lepri, Alessandro
Prinapori, Roberta
Angarano, Gioacchino
Gori, Andrea
Quirino, Tiziana
De Luca, Andrea
Mussini, Cristina
Rizzardini, Giuliano
Castagna, Antonella
Antinori, Andrea
dʼArminio Monforte, Antonella
COSTANTINI, ANDREA

January 2016

Background: Study aim was to estimate the rate and identify predictors of discontinuation of first c...

Insights into reasons for discontinuation according to year of starting first regimen of highly active antiretroviral therapy in a cohort of antiretroviral-naïve patients

Cicconi, P
Cozzi Lepri, A
Castagna, A
Trecarichi, EM
Antinori, A
Gatti, F
Cassola, G
Sighinolfi, L
Castelli, P
d'Arminio Monforte, A
PERNO, CARLO FEDERICO

February 2010

The aim of the study was to determine whether the incidence of first-line treatment discontinuations...

and population-level health consequences of discontinuing antiretroviral therapy in settings with

Abstract

Extracted data

and population-level health consequences of discontinuing antiretroviral therapy in settings with

Abstract

Extracted data

Related items

Related items